ICU Medical (Nasdaq: ICUI) is expected to report Q2 earnings around July 16. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict ICU Medical's revenues will increase 8.0% and EPS will expand 4.8%.

The average estimate for revenue is $83.4 million. On the bottom line, the average EPS estimate is $0.66.

Revenue details
 Last quarter, ICU Medical booked revenue of $74.3 million. GAAP reported sales were 1.6% lower than the prior-year quarter's $75.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, EPS came in at $0.58. GAAP EPS of $0.58 for Q1 were 9.4% higher than the prior-year quarter's $0.53 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 49.5%, 320 basis points better than the prior-year quarter. Operating margin was 16.2%, 110 basis points better than the prior-year quarter. Net margin was 11.7%, 160 basis points better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $334.2 million. The average EPS estimate is $2.81.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 83 members out of 98 rating the stock outperform, and 15 members rating it underperform. Among 30 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 27 give ICU Medical a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ICU Medical is outperform, with an average price target of $69.50.

Is ICU Medical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.